Sofiya Gancheva

Sofiya Gancheva

Auto-generated profile, based on publicly available information

Sofiya Gancheva

Department of Nutrition, Diabetes and Metabolism, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2025 in Science Advances
Verified
Journal Article
Open access
DPDominik Pesta
Dominik Pesta
EAEvrim Anadol-Schmitz
Evrim Anadol-Schmitz
TSTheresia Sarabhai
Theresia Sarabhai
YKYvo Op Den Kamp
Yvo Op Den Kamp
SGSofiya Gancheva
Sofiya Gancheva
MRMichael Roden
Michael Roden
The athlete’s paradox states that intramyocellular triglyceride accumulation associates with insulin resistance in sedentary but not in endurance-trained humans. Underlying mechanisms and the role of muscle lipid distribution and composition on glucose metabolism remain unclear. We compared highly trained athletes (ATHL) with sedentary normal weight (LEAN) and overweight-to-obese (OVWE) male and female individuals. This observational study found that ATHL show higher insulin sensitivity, muscle mitochondrial content, and capacity, but lower activation of novel protein kinase C (nPKC) isoforms, despite higher diacylglycerol concentrations. Notably, sedentary but insulin sensitive OVWE feature lower plasma membrane-to-mitochondria sn -1,2-diacylglycerol ratios. In ATHL, calpain-2, which cleaves nPKC, negatively associates with PKCε activation and positively with insulin sensitivity along with higher GLUT4 and hexokinase II content. These findings contribute to explaining the athletes’ paradox by demonstrating lower nPKC activation, increased calpain, and mitochondrial partitioning of bioactive diacylglycerols, the latter further identifying an obesity subtype with increased insulin sensitivity (NCT03314714).

21 August 2026 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
SGSofiya Gancheva
Sofiya Gancheva
OPOslando Padilla
Oslando Padilla
PMPaula Margozzini
Paula Margozzini
SSSandra Solari
Sandra Solari
VSValentina Serrano
Valentina Serrano
ARAttilio Rigotti
Attilio Rigotti
Background: Understanding diabetes heterogeneity across diverse populations is critical for advancing precision medicine. However, population-representative data on diabetes subphenotypes in South America are scarce. We examined Ahlqvist-derived diabetes clusters in nationally representative cohorts of Chilean adults and their associations with complications and mortality. Methods: This complex-sample analysis included 308 and 536 adults with diabetes from the Chilean National Health Survey (2009–2010 and 2016–2017). Participants were classified as Mild Age-Related Diabetes (MARD), Mild Obesity-Related Diabetes (MOD), Severe Insulin-Resistant Diabetes (SIRD), or Severe Insulin-Deficient Diabetes (SIDD) using the approach of Bello-Chavolla et al. Self-reported complications and all-cause mortality were assessed, with up to 13 years of follow-up. Results: Subtype distributions were consistent across survey waves, with increasing MOD prevalence over time. SIDD was characterized by longer diabetes duration and poor glycaemic control. It exhibited up to threefold higher albuminuria, also among recently diagnosed individuals. In unadjusted analyses, SIDD showed higher mortality risk (HR 4.87, 95% CI 1.87–12.70), whereas MOD demonstrated mortality comparable to normoglycaemic individuals. After multivariable adjustment, the association between SIDD and mortality was attenuated and no longer significant, while HbA1c emerged as a key determinant of mortality risk. Conclusions: In contrast to findings in European populations, SIDD was associated with early kidney involvement and higher unadjusted mortality risk in Chile, whereas MOD represents a relatively lower-risk subtype. However, the mortality association was not independent of conventional risk factors, particularly HbA1c. These findings support the clinical utility of diabetes subphenotyping for risk stratification in public health settings, while underscoring the importance of population-specific validation.